Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: Experience with 130 patients with biopsy confirmed tumor

Journal of Urology

Volumn 164, Issue 6, 2000, Pages 1926-1928

  Casella, Roberto ^a,b   Huber, Peter ^a,b   Blöchlinger, Andrea ^a,b   Stoffel, Flavio ^a,b   Dalquen, Peter ^a,b   Gasser, Thomas C ^a,b   Lehmann, Kurt ^a,b,c  

^a Urologische Klinik Universitatsspital Basel   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c PFIZER INC   (United States)

Author keywords

Bladder neoplasms; Cytology; Nuclear matrix; Proteins

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CELL NUCLEUS MATRIX; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TRANSITIONAL CELL CARCINOMA;

EID: 0033757860     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66920-0     Document Type: Article

References (12)

1. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms
2. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract
3. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder
4. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?
5. Comparison of screening methods in the detection of bladder cancer
6. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: Comparison with urinary cytology and BTA test
7. Evaluation of nuclear matrix protein 22 as a turnout marker in the detection of transitional cell carcinoma of the bladder
8. Pussycats and baby tigers: Non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same!
9. Tumors of the urinary tract and prostate in urinary sediment
10. Utilisation of nuclear matrix proteins for cancer diagnosis
11. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer
12. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer